A Medicines Supply Notification (MSN) issued on 14
February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser
liquid. The resolution date is to be confirmed.
The supply issues have been caused by a combination
of manufacturing issues resulting in increased demand on other suppliers.
Terbutaline,
salbutamol with ipratropium, and ipratropium nebuliser liquids remain
available, however, they cannot support an increase in demand.
Ventolin®
(salbutamol) 5mg/ml nebuliser liquid (20ml) is out of stock until mid-April
2024 and cannot support an increased demand after this date.
This National Patient Safety Alert provides further background and clinical information and actions for providers.